Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-11 of 11
Keywords: Clinical trial
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Carlo Buonerba, Alessia Nunzia Calabrese, Giuseppe Imperioso, Arianna Piscosquito, Antonio Verde, Angelo Vaia, Luca Scafuri, Felice Crocetto, Davide Leopardo, Bernardo Rocco, Francesco Del Giudice, Antonio Tufano, Beniamino Casale, Francesca Cappuccio, Francesco Chiancone, Rossella Di Trolio, Giuseppe Di Lorenzo
Journal:
Oncology
Oncology (2024) 102 (8): 659–662.
Published Online: 23 January 2024
.... The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Bidirectional communication Clinical trial Healthcare providers Instant messaging Patient care...
Journal Articles
Takayuki Ando, Ayumu Hosokawa, Miho Sakumura, Iori Motoo, Shinya Kajiura, Katsuhisa Hirano, Takeshi Miwa, Tomotaka Yokota, Naokatsu Nakada, Yuko Ueda, Akira Ueda, Kenichiro Tsukada, Kohei Ogawa, Atsuko Nakaya, Akira Teramoto, Sohachi Nanjo, Hiroshi Mihara, Haruka Fujinami, Tsutomu Fujii, Ichiro Yasuda
Journal:
Oncology
Oncology (2023) 101 (1): 59–68.
Published Online: 24 January 2023
... Yasuda Introduction: Third-line chemotherapy has been suggested to improve survival in patients with gastric cancer. This study aimed to identify factors associated with the induction of third-line chemotherapy for advanced gastric cancer, focusing on patient eligibility for clinical trial. Methods: We...
Journal Articles
Subject Area:
Oncology
Melanie B. Thomas, Elizabeth Garrett-Mayer, Munazza Anis, Kate Anderton, Tricia Bentz, Andie Edwards, Alan Brisendine, Geoffrey Weiss, Abby B. Siegel, Johanna Bendell, Ari Baron, Vinay Duddalwar, Anthony El-Khoueiry
Journal:
Oncology
Oncology (2018) 94 (6): 329–339.
Published Online: 02 May 2018
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Hepatocellular carcinoma Hepatoma Clinical trial Sorafenib Bevacizumab Erlotinib...
Journal Articles
Subject Area:
Oncology
Mehran Yusuf, Beatrice Ugiliweneza, Mark Amsbaugh, Maxwell Boakye, Brian Williams, Megan Nelson, Eyas M. Hattab, Shiao Woo, Eric Burton
Journal:
Oncology
Oncology (2018) 95 (1): 39–42.
Published Online: 25 April 2018
... and adjuvant temozolomide (TMZ) [ 2, 3 ]. Glioblastoma Elderly Hypofractionated Combined modality Radiation Temozolomide Clinical trial © 2018 S. Karger AG, Basel 2018 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (2017) 93 (Suppl. 1): 127–134.
Published Online: 20 December 2017
...Masatoshi Kudo; Tadaaki Arizumi The multikinase inhibitor sorafenib is the first oral molecular targeted agent with proven prognostic benefit in unresectable advanced hepatocellular carcinoma (HCC). However, as with other drugs, sorafenib has its limitations, and various clinical trials have been...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (2014) 86 (3): 177–184.
Published Online: 16 April 2014
... to in the content or advertisements. Metastatic spinal cord compression Malignant cord compression Clinical trial Malignancy Prognosis Surgery Spine surgeons as well as physical medicine and rehabilitation specialists are in need of a clinical algorithm for patients with vertebral metastases...
Journal Articles
Subject Area:
Oncology
Hirofumi Mukai, Toru Watanabe, Michihide Mitsumori, Hitoshi Tsuda, Seigo Nakamura, Norikazu Masuda, Naohito Yamamoto, Taro Shibata, Akihiro Sato, Hiroji Iwata, Kenjiro Aogi
Journal:
Oncology
Oncology (2013) 85 (6): 336–341.
Published Online: 12 November 2013
... as the time from randomization to death from any cause, and was censored at the final follow-up date. Toxicity was evaluated according to National Cancer Institute Common Toxicity Criteria (version 2). Chemotherapy Clinical trial Doxorubicin Early stage breast cancer Paclitaxel Preoperative...
Journal Articles
Subject Area:
Oncology
Han Hsi Wong, Charlotte Siegler, Samantha Grainger, Kamarul Ahmad Zaki, Athena Matakidou, Tim Eisen, Kate Fife
Journal:
Oncology
Oncology (2013) 85 (5): 297–298.
Published Online: 06 November 2013
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Clinical trial Renal cell carcinoma Clinical trials are vital...
Journal Articles
Subject Area:
Oncology
Montserrat Blanco Codesido, Andre Tesainer Brunetto, Sophia Frentzas, Victor Moreno Garcia, Dionysis Papadatos-Pastos, Joanna Vitfell Pedersen, Leonardo Trani, Martina Puglisi, L. Rhoda Molife, Udai Banerji
Journal:
Oncology
Oncology (2011) 81 (2): 135–140.
Published Online: 06 October 2011
... treatments for patients with metastatic melanoma (MM) are unsatisfactory. We analyzed the clinical outcomes of patients with MM treated in phase I trials of novel agents. We hypothesized that patients included in phase I clinical trials did not have worse outcomes than with the chemotherapy and cytokine...
Journal Articles
Subject Area:
Oncology
Edith A. Perez, Vera J. Suman, Tom R. Fitch, James A. Mailliard, James N. Ingle, John T. Cole, Michael H. Veeder, Patrick J. Flynn, Daniel J. Walsh, Ferdinand K. Addo
Journal:
Oncology
Oncology (2005) 69 (2): 117–121.
Published Online: 21 September 2005
...Edith A. Perez; Vera J. Suman; Tom R. Fitch; James A. Mailliard; James N. Ingle; John T. Cole; Michael H. Veeder; Patrick J. Flynn; Daniel J. Walsh; Ferdinand K. Addo Objective: A phase II multi-institutional clinical trial conducted to evaluate the efficacy and tolerability of docetaxel...
Journal Articles
Subject Area:
Oncology
Journal:
Oncology
Oncology (2004) 66 (2): 138–142.
Published Online: 14 May 2004
... with poor PS should not be treated with chemotherapy at present. It is essential to design good clinical trials and develop more effective chemotherapy regimens. It is unclear if chemotherapy could act favorably for BTC patients. To examine the potential benefit of chemotherapy on BTC patients’ survival...